US Patent Issued to Zhejiang SUKEAN Pharmaceutical on Aug. 12 for "Serum metabolic biomarkers and kit for detecting drug-resistant tuberculosis" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,385,916, issued on Aug. 12, was assigned to Zhejiang SUKEAN Pharmaceutical Co. Ltd. (Hangzhou, China).

"Serum metabolic biomarkers and kit for detecting drug-resistant tuberculosis" was invented by Pintong Huang (Hangzhou, China), Yajing Liu (Hangzhou, China), Yan Su (Hangzhou, China) and Chao Zhang (Hangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A set of serum metabolic biomarkers and detection kit for detecting drug-resistant tuberculosis are provided. The set of the serum metabolic biomarkers includes 17 serum metabolic biomarkers. The 17 serum metabolic biomarkers are verified to be associated with tuberculosis based on the level cha...